Early postoperative recurrence of severe crohn's disease, with colonic involvement and associated human cytomegalovirus infection, treated with oral valganciclovir and adalimumab

Inflammatory Bowel Diseases

Volumn 17, Issue 6, 2011, Pages

  Sinagra, Emanuele ^a   Renna, Sara ^a   Mocciaro, Filippo ^a   Olivo, Mirko ^a   Cottone, Mario ^a   Orlando, Ambrogio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; C REACTIVE PROTEIN; CORTICOSTEROID; CYTOMEGALOVIRUS ANTIGEN PP65; ENEMA; EOSIN; HEMATOXYLIN; VALGANCICLOVIR;

ADULT; CASE REPORT; COLON BIOPSY; COLONOSCOPY; CORTICOSTEROID THERAPY; CROHN DISEASE; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CYTOMEGALOVIRUS; HYPOALBUMINEMIA; INTESTINE ANASTOMOSIS; INTESTINE OBSTRUCTION; INTESTINE RESECTION; LETTER; LEUKOCYTOSIS; MALNUTRITION; MEGACOLON; NONHUMAN; PARENTERAL NUTRITION; PELVIS ABSCESS; PRIORITY JOURNAL; RECURRENT DISEASE; WEIGHT REDUCTION;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; CROHN DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GANCICLOVIR; HUMANS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECURRENCE;

EID: 79955851848     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21685     Document Type: Letter

References (8)

1. Rahier JF, Ben-Horin S, Chowers Y, et al. European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2009; 3: 47-91.
2. Van Assche G, Vermeire S, Rutgeerts P,. Adalimumab in Crohn's disease. Biologics. 2007; 1: 355-365.
3. Kandiel A, Lashner B,. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol. 2006; 101: 2857-2865. (Pubitemid 44902661)
4. Kim J, Simpson N, Klipfel N, et al. Cytomegalovirus infection in patients with active inflammatory bowel disease. Dig Dis Sci. 2010; 55: 1059-1065.
5. Lawlor G, Moss A,. Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander? Inflamm Bowel Dis. 2010; 16: 1620-1627.
6. Orlando A, Armuzzi A, Papi C, et al. Clinical practice guidelines: the use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease. Dig Liver Dis. 2011; 43: 1-20.
7. CvetkoviÄ RS, Wellington K,. Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients. Drugs. 2005; 65: 859-878. (Pubitemid 40598096)
8. Levesque BG, Pai R, Cartwright CA,. Crohn's colitis complicated by cytomegalovirus infection. Dig Dis Sci. 2009; 54: 1864-1867.